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SUMMARY 
Ischemic stroke is the third leading cause of death and the leading cause for permanent adult 
neurological disability in the developed countries. Its acute treatment is possible for a 
subgroup of patients only within three to six hours after symptom onset. As the early 
therapeutic decision is essential, identifying individual patients of this subgroup has been a 
diagnostic challenge. Recently, functional magnetic resonance imaging (fMRI) techniques, 
diffusion weighted imaging (DWI) and dynamic susceptibility contrast (DSC) perfusion 
imaging, have shown promise in being capable of characterizing the ischemic tissue, in the 
form of apparent diffusion coefficient (ADC), and the abnormal hemodynamics associated 
with it in the form of cerebral blood volume (CBV), cerebral blood flow (CBF), contrast 
agent mean transit time (MTT), and cerebral blood flow heterogeneity (FH). This study aimed 
to assess the variation of these commonly used indices in a normal aging population, and to 
characterize the behaviour of these indices in ischemic stroke patients. The study consists of 
five publications; the first two reporting the behaviour of DWI and DSC MRI –based indices, 
respectively, in a normal aging population, and the last three reporting the four different DSC 
MRI based indices in untreated ischemic stroke patients. The study showed that, in general, 
the indices are not affected by aging. Further, it was shown that the method of determining 
CBV and MTT does not affect the visual interpretation of tissue at risk, but has to be taken 
into account for quantitative analysis and automated interpretation algorithms. Finally, it was 
shown that the hemodynamical abnormality caused by ischemic stroke reduces in size during 
the first week whereas the ischemic core itself enlarges in naturally evolving stroke. The 
study enhances the basis of applying DWI and DSC MRI in ischemic stroke patients by 
reporting the effect of normal aging and normal brain subregional differences in the indices as 
well as the evolution of the hemodynamically abnormal tissue volumes in an untreated 
ischemic stroke during the first week. Further, by reporting the failure of traditional and the 
success of more novel methods to accurately determine CBV and MTT, the study lays ground 
for quantitative measures of DSC MRI indices. 
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1 INTRODUCTION 
Cerebral functions rely on adequate oxygen delivery to meet the metabolic demands of the 
functioning neurons. Oxygen, and other nutrients, are delivered to cerebral tissue through the 
cerebrovascular system and the endothelial lining of the cerebral capillaries. Within certain 
functional limits, cerebral autoregulation ensures sufficient transport of metabolites during the 
varying requirements posed by local neuronal tissue. However, outside these functional limits, 
cerebral autoregulation breaks down and insufficient amounts of oxygen and other nutrients 
reach the tissue for it to function normally. Severe lack of oxygen causes neuronal tissue to 
cease functioning in a matter of minutes with the damage becoming irreversible within a few 
hours. The acute reduction of blood supply, acute stroke, is one of the major causes of adult 
neurological disability and one of the leading causes of death in the developed countries 
(Beauchamp and Bryan, 1998). In four of five strokes, the abrupt decline in oxygen delivery is 
due to a local blockage of blood flow and referred to as ischemic stroke (Schellinger et al., 
2004). Luckily, the progression of ischemic stroke can many times be inhibited by 
thrombolytic therapy targeted at dissolving the clot, which blocks the blood flow, provided 
the therapy can be administered within 3 or 6 hours after the onset of symptoms (Group, 1995; 
Hacke et al., 1998). However, the thrombolytic therapy can lead to complications and is 
contraindicated by hemorrhage posing the need to assess the risks involved with the therapy 
separately in each individual case.  
Magnetic resonance imaging (MRI) is an increasingly available radiological 
tool, which allows the rapid assessment of cerebrovascular disease. The physical principles 
forming the basis of MRI were discovered in the 1940’s (Bloch et al., 1946; Purcell et al., 
1946) and awarded the Nobel Prize in physics in 1952. However, the methodology evolved 
into a clinical tool only after several decades and further discoveries (Lauterbur, 1973; 
Mansfield, 1977), which were awarded the Nobel Prize in medicine in 2003. In the advent of 
MRI’s clinical era, in the late 1970’s and early 1980’s, its use was confined to anatomical 
imaging mainly based on soft tissue contrast, which was far superior to its diagnostic 
competitors, computed tomography, ultrasound, and the methods based on nuclear medicine. 
In addition to its strengths in forming different tissue contrasts, the growth of MRI as a 
clinical tool was supported by the freely selectable slice orientation and the complete lack of 
ionizing radiation. As the signal detection concepts and the power of hardware evolved, the 
spatial and temporal resolutions of MRI increased creating an opportunity to detect tissue 
functionality with MRI. In the late 1980’s, magnetic resonance angiography (Wedeen et al., 
1985), diffusion weighted imaging (DWI) (Le Bihan et al., 1986; Le Bihan et al., 1988) and 
dynamic susceptibility contrast (DSC) –based perfusion imaging (Villringer et al., 1988) were 
introduced. Due to the wide range of contrast formation and imaging techniques, MRI has a 
high diagnostic capability and applications in a versatility of pathologies. One major group of 
these pathologies is neurological disorders. 
The present study focuses on the use of DWI and DSC MRI in describing 
human ischemic stroke. The study is composed of 5 publications and a summary. The first 
two publications describe DWI and DSC MRI findings in normal population laying the 
foundation for applying these methods in the diseased brain. The third publication compares 
four different approaches for determining  cerebral blood volume (CBV) and contrast agent 
mean transit time (MTT). The fourth publication investigates the possibility of predicting the 
evolution of the infarct based only on knowledge of tissue perfusion in the form of cerebral 
blood flow (CBF) at 24hrs after symptom onset. The fifth publication follows the course of 
the sizes of CBV, CBF, MTT, and cerebral blood flow heterogeneity (FH) abnormalities 
during the first week of developing infarct. Thus the first two publications describe the 
methods in normal material, and the last three publications focus on the application of CBV, 
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CBF, MTT and FH in ischemic stroke. The summary section provides background of the 
theory utilized in the publications and puts the results into perspective with present advances 
in the field. 
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2 CEREBRAL HEMODYNAMICS AND ITS AUTOREGULATION 
Tissue regulates and meets its needs for metabolic substrates through cerebral hemodynamics. 
The exchange of substances, e.g. oxygen and carbon dioxide, between blood and tissue 
operates at the microvascular level, where the diameter of the capillaries is only around 5µm. 
Blood-brain-barrier (BBB), the tight junctions between capillary endothelial cells, restricts the 
exchange preventing proteins and polypeptides from entering the brain whereas allowing the 
passive transport of water, carbon dioxide and oxygen (Ganong, 2001). 
 Cerebral autoregulation seeks to maintain CBF relatively constant despite 
variations in cerebral perfusion pressure (CPP). Changes in CPP over a wide range have only 
a small effect on CBF (Powers, 1991). This autoregulation is mediated through 
cerebrovascular resistance so that when CPP is reduced, the ratio CBV:CBF is increased. 
Another part of tissue oxygen metabolism regulation mechanism is considered to be the 
distribution of CBF (Kuschinsky and Paulson, 1992), which in normal capillaries is wide 
around a mean flow (Kuschinsky and Paulson, 1992; Hudetz et al., 1996). In cases of lowered 
local CPP there is a significant reduction in the high flow components leading to a less 
dispersed flow velocity distribution (Hudetz, et al., 1996; Vogel and Kuschinsky, 1996), 
which improves oxygen delivery to the tissue (Kuschinsky and Paulson, 1992; Østergaard et 
al., 2000). However, when the capacity for compensatory vasodilation has been exceeded, 
autoregulation fails (Powers, 1991). Any further reduction in CPP produces a decrease in 
CBF. With decreasing CBF, oxygen extraction fraction (OEF) increases to maintain the 
cerebral metabolic rate of oxygen (CMRO2) to drive neuronal function. Should the CPP 
continue to fall, the increase in OEF at some point is no longer adequate to supply the energy 
needs of the brain (Sette et al., 1989) and brain dysfunction results. If circulation is rapidly 
restored, the dysfunction may be reversible, otherwise the damage is irreversible resulting in 
an infarct. 
 Infarction is caused by a severely reduced blood flow in a vessel due to e.g. 
thrombus of artherosclerotic plaque. The reduced blood flow leads to hypoxia, or even anoxia, 
but in any case to an interruption of the oxygen supply of the tissue perfused by the clotted 
vessel and subsequently to ischemic stroke. Consequently, the primary goal of acute stroke 
treatment is to restore normal blood flow as soon as possible. This is performed primarily by 
the use of clot-lysing drugs, which have to be applied as soon as possible after the clot 
formation to ensure the restoration of the function of the damaged neurons. As the application 
of clot-lysing drugs is contraindicated in hemorrhagic stroke, the diagnosis of the quality and 
extent of stroke is extremely important in making the therapeutic decision in the early phase 
of stroke. MRI provides a possibility to assess these aspects of stroke with DWI and DSC 
MRI. 
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3 MEASUREMENT OF TISSUE WATER DIFFUSION BY MAGNETIC 
RESONANCE IMAGING 
3.1 Water diffusion in tissue 
In human tissue, the water molecules are constantly in random Brownian motion due to their 
thermal energy. The surroundings of the tissue water molecules contain obstacles, such as 
membranes, which the molecules cannot readily penetrate. The path of a single water 
molecule therefore reflects the structure of its microscopic environment. As the intracellular 
space contains far more obstacles than the extracellular space, the diffusion is more restricted 
in the intracellular space. Although, this Brownian motion is based on the intermingling of the 
water molecules and is thus a microscopic phenomenon, as large amounts of molecules are 
involved it gives rise to a macroscopically observable and measurable phenomenon known as 
diffusion. 
 
3.2 Diffusion weighted magnetic resonance imaging 
The phenomenon of nuclear magnetic resonance (NMR) was initially discovered by Bloch 
(Bloch, 1946; Bloch, et al., 1946) and Purcell (Purcell, et al., 1946) followed by the 
introduction of the principle of spin echo by Hahn (Hahn, 1950), which included the notion 
that the random thermal incoherent motion of the spins would reduce the amplitude of the 
observed spin echo signal in the presence of a magnetic field inhomogeneity. In essence, it 
stated that any spin echo –based pulse sequence is sensitive to incoherent motion of water 
molecules due to the facts that the molecules have time to diffuse between the excitation pulse 
and the reversing π-pulse as well as between the π-pulse and the time of the echo and that the 
motions at these two time windows are not correlated. In conventional pulse sequences, 
however, the time is too short for any significant diffusion weighting to be present and for the 
effect of diffusion to be measurable. Consequently, the measurement time has to be prolonged 
or the effect of diffusion amplified during the short measurement time. Founding on the work 
of Carr and Purcell (Carr and Purcell, 1954) and Torrey (Torrey, 1956), Stejskal and Tanner 
(Stejskal and Tanner, 1965) developed the methodology and theory of the pulsed gradient spin 
echo experiment, which made possible the direct measurement of the diffusion and opened 
the window for quantitative measurements of molecular diffusion coefficients. The method is 
based on amplifying the effect of the inherent diffusion on the MR signal by additional 
diffusion gradients set symmetrically on either side of the reversing π-pulse. The 
measurement of water diffusion by MRI was made possible by the pioneering work by 
Lauterbur (Lauterbur, 1973) introducing imaging gradients and by Mansfield (Mansfield, 
1977; Mansfield, 1984) introducing ultrafast echo planar imaging (EPI) technique. Imaging 
gradients allowed spatial localization of measured signal in the imaging volume and were thus 
a prerequisite for imaging in general. EPI technique shortens considerably the time required to 
form an image due to the filling of the k-space after only one single excitation pulse. The 
drawback of EPI is lower signal-to-noise ratio (SNR) than in conventional imaging, but the 
benefits of rapid data collection are indispensable in imaging water diffusion. 
DWI is based on introducing diffusion gradients in a basic spin echo 
experiment. Any phase shift due to the motion of a spin during the diffusion gradient is 
amplified by the gradients. By positioning the diffusion gradients symmetrically around the π-
pulse, the amplification is effectively eliminated for stationary spins, but for incoherently 
moving spins the amplified phase shift leads to a temporally distorted echo and subsequently 
decreases the echo signal of the whole spin ensemble of the voxel. The first diffusion images 
on a whole-body system were obtained by Le Bihan (Le Bihan, et al., 1986; Le Bihan, et al., 
9 
1988) and the clinical importance of diffusion imaging as being capable of detecting ischemic 
tissue within minutes after stroke in an experimental animal model was demonstrated by 
Moseley et al (Moseley et al., 1990) and in human ischemia by Warach et al (Warach et al., 
1992). 
 
3.3 Diffusion weighted magnetic resonance imaging in acute stroke 
The detection of ischemia with DWI is based on the alteration of water diffusion due to the 
pathology. The MR signal from an imaging voxel includes components from both intra- and 
extracellular water. As the diffusion of intracellular water is more restricted than the diffusion 
of extracellular water due to limiting structures such as microparticles and membranes, the 
fraction of intracellular water to extracellular water is directly reflected in the measured 
diffusion from a particular voxel. In acute stroke, the breakdown of sodium-potassium pumps 
leads to cytotoxic edema and to the growth of the fraction of intracellular space within an 
imaging voxel. This effectively results in a net decrease of the measured diffusion in the 
voxel.  
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4 MEASUREMENT OF TISSUE PERFUSION WITH DYNAMIC 
SUSCEPTIBILITY CONTRAST MAGNETIC RESONANCE 
IMAGING 
Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI) provides the means 
for non-invasive in vivo assessment of normal and diseased microvascular system, which has 
earlier been impossible due to the lack of appropriate techniques sensitive at the capillary 
level. DSC MRI is based on the use of single shot EPI techniques (Mansfield, 1977) and 
susceptibility contrast (Villringer, et al., 1988) induced by gadolinium –based contrast agents, 
which have allowed the measurement of the first pass circulation of contrast agents through 
the brain (Rosen et al., 1990; Belliveau et al., 1991; Rosen et al., 1991a; Rosen et al., 1991b). 
The dynamic data sets collected during the first pass circulation through the brain can be used 
to generate different functional maps of the in vivo hemodynamics of the normal and 
pathological brain (Belliveau et al., 1990). These maps can be used to characterize and 
measure various aspects of structure and hemodynamics of normal and diseased 
microvascular system. The first reported functional MRI study demonstrating increased local 
CBV in response to neuronal activation was based on DSC MRI (Belliveau, et al., 1991). 
 
4.1 Susceptibility contrast 
Paramagnetic substances distort the magnetic field through short-range interactions due to 
their large magnetic moments and dipole-dipole interactions. They affect both the observed 
T1 and T2 relaxation times due to the interactions between the unpaired electrons of the 
paramagnetic ion and the hydrogen nuclei of water molecules (Bloembergen et al., 1948; 
Solomon, 1955; Bloembergen, 1957). The modification of tissue contrast due to T2 relaxation 
enhancement is referred to as susceptibility contrast. The effect of the paramagnetic substance 
to both T1 and T2 is dependent on a dipole-dipole term and a scalar component. The dipole-
dipole term describes the ability of tissue water protons to approach the paramagnetic center 
of the contrast agent. Thus the relaxivity increases with the amount of water protons capable 
of moving into close proximity of the agent. Further, as the magnetic moment of an unpaired 
electron spin is 657 times greater than that of a proton, the relaxation efficiency of an electron 
is very high. Subsequently, metal ions that have several unpaired electrons are efficient agents 
in enhancing relaxivity. The scalar component describes the probability of contact interaction 
between the unpaired electron of the paramagnetic substance and water proton nucleus in the 
form of correlation time including rotation, electron spin relaxation, and chemical exchange 
components. Thus, the longer it takes for the paramagnetic ions to rotate, or the longer the 
electron spin relaxation time is, the more efficient is the relaxivity effect of the contrast agent. 
Most popular contrast agents in the clinical setting are gadolinium and dysprosium, which 
both have a large net molecular magnetic moment due to large number of unpaired electron 
spins coupled with relatively long electron spin relaxation times. Due to their inherent 
toxicity, gadolinium and dysprosium are typically applied in the vasculature chelated to a 
ligand molecule, such as diethylenetriaminepentaacetic acid (DTPA). 
Susceptibility contrast was introduced into human MRI studies by Villringer et 
al (Villringer, et al., 1988), showing that, in addition to the T1-effect, the paramagnetic 
contrast agent has the ability to alter T2 relaxation rates if present in high enough 
concentrations and compartmentalized into intravascular space. The high concentration of an 
intravascular paramagnetic contrast agent produces a magnetic susceptibility difference 
between the capillaries filled with the contrast agent and the surrounding tissue. The 
susceptibility difference in turn produces local magnetic field gradients extending to a 
distance outside the vessel roughly equal to the vessel diameter. As water molecules diffuse 
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through these field gradients they rapidly lose their phase coherence leading to an increase in 
T2 (and T2*) relaxation rates. The magnetic susceptibility effect thus results from local 
magnetic field gradients induced by intravascular compartmentalization of the contrast agent 
and it dominates over the T1 relaxation enhancement in high concentrations (Villringer, et al., 
1988).  
 
4.2 Relation of signal and concentration 
As DSC imaging is based on nuclear magnetic resonance, it detects primarily tissue water 
protons, not the contrast agent molecules. Thus, in DSC imaging, the measured signal is not 
directly a measure of the contrast agent concentration. Rather, the signal arises from the 
changes in the characteristics of tissue water protons due to the susceptibility effect induced 
by the external contrast agent and is a measure of T2 (or T2*) relaxation rate, denoted as R2 
(or R2*) (Villringer, et al., 1988). The signal intensity, S(t), measured in the DSC MRI 
experiment can be expressed as  
 
21
0 )-)(1()(
RTERTR eetStS ∆⋅−∆⋅−= ,  [1] 
 
where S(t0) is the initial signal intensity, TR is repetition time, and TE echo time. According to 
both empirical measurements (Villringer, et al., 1988; Rosen, et al., 1990; Lev et al., 1997) 
and theoretical simulations (Fisel et al., 1991; Kennan et al., 1994; Weisskoff et al., 1994b; 
Boxerman et al., 1995), in the clinically applicable range, there is an approximately linear 
relationship between the change in the R2 (or R2*), relaxation rate and the concentration 
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Substituting Eq. [2] to Eq [1] and assuming T1 to remain unchanged during the measurement, 
the concentration can be expressed 
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where k is a proportionality constant, which depends on the properties of the contrast agent 
and tissue.  
 
4.3 Principles of tracer kinetics – Indicator dilution theory 
The kinetics of a non-diffusible contrast agent can be described by indicator dilution theory 
(Meier and Zierler, 1954; Lassen and Perl, 1979). An indicator is defined as an identifiable 
substance, which is introduced into blood circulation, either as an instantaneous bolus 
injection or by continuous intravascular infusion, and which is subsequently diluted in the 
circulation. Indicator dilution theory describes the behaviour of such a substance in the 
vasculature. Indicator dilution theory requires the indicator to remain in the vasculature, 
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which in cerebral microvasculature translates into a requirement of an intact blood-brain-
barrier. In the case of a disrupted BBB, the contrast agent is able to leak into the tissue and 
distort the contrast by acting as a diffusible contrast agent. Thus an intact BBB is a 
prerequisite for using the indicator dilution methodology for assessing tissue perfusion. 
The indicator dilution methodology can be used to measure blood volume and 
blood flow as the volume of solution necessary to dilute the injected indicator to equal the 
observed concentration is exactly the volume of blood that had diluted the injectate over the 
time interval in which indicator was recovered (Stewart, 1894). The output concentration, c(t), 
is a convolution of the input function, ca(t), and the probability density function of transit 
times h(t) (Meier and Zierler, 1954) 
 
∫ −= t a dthctc
0
)()()( τττ .   [4] 
 
According to Eq. [4] the output (or venous) concentration is a convolution between the input 
function and the probability density function of transit times. In DSC MRI, the frequency 
function of transit times is not measured directly. Rather, the residue function, which 
describes the amount of contrast agent present in the vasculature is measured. The residue 
function is defined as (Østergaard et al., 1996c) 
 
∫−= t dhtR
0
)(1)( ττ ,   [5] 
 
with R(0)=1, R(∞)=0 and R(t) being a monotonically decreasing function of time. The 
observed tissue concentration, ct(t), becomes (Østergaard, et al., 1996c) 
 
∫ −⋅= t at dtRcCBFtc
0
)()()( τττ .  [6] 
 
According to Eq. [6], the impulse response function, )(tRCBF ⋅ , can be determined through 
deconvolution, assuming ct(t) and ca(t) are known. As CBF is a scalar, the impulse response 
function is shaped by the residue function and as the residue function is normalized to unity, 
the impulse response function is scaled by CBF. This essentially suggests that as R(0)=1, the 
height of the impulse response at that point corresponds to CBF.  
 
4.4 Tissue impulse response 
Tissue impulse response holds information on tissue blood flow characteristics on several 
aspects. As the underlying distribution, the residue function, is a probability density function, 
the height of the impulse response is directly scaled by CBF (Østergaard et al., 1996b; 
Østergaard, et al., 1996c). Thus, the impulse response holds information of the mean CBF in 
the voxel. Further, the integral over the impulse response function equals to the CBV in the 
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voxel whereas, as indicated by the central volume theorem, the integral over the residue 
function equals to the MTT (Paper III). However, in addition to CBV, CBF, and MTT, the 
impulse response function can be utilized to extract additional information of the capillary 
blood flow characteristics of the voxel, although it requires modeling the vasculature to some 
degree (Østergaard et al., 1999).  
Tissue impulse response is obtained by deconvolving Eq. [6] usually by a 
model-independent method, such as singular value decomposition (SVD) (Østergaard, et al., 
1996b; Østergaard, et al., 1996c). SVD was developed by several mathematicians during the 
19th and 20th century (Stewart, 1993) and is based on the fact that every m x n (m ≥ n) matrix 
can be deconstructed into the product of three matrixes U · S · VT, where U and V are 
orthogonal matrices, such that  UT · U = VT · V = I, and S is a nonnegative diagonal matrix 
constituting of the singular values of matrix, i.e. S = diag(σ1,σ2,…,σn), where σ are the 
singular values. The utilization of SVD in the context of DSC MRI requires discretization of 
Eq. [6] so that  
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where ∆t is the sampling interval of the DSC MRI experiment. Eq. [7] can further be 
expanded into matrix notation c = A · b, where b includes the elements of the impulse 
response function, A the elements of the arterial input function, and c the elements of output 
concentration. Tissue impulse response, b, can be solved using SVD as b = V · W · UT · c, 
where V · W · UT  = A-1 and W = diag(σ1-1,σ2-1,…,σn-1). Further, the elements of the diagonal 
matrix W are set to 
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where ε is a singularity threshold usually set to some fixed percentage of σmax.  
 Whereas SVD represents a model-independent technique to solve tissue impulse 
response, it can be supplemented with a vascular model to enhance the information content 
obtained from the tissue impulse response. Based on the vascular model developed by Kroll et 
al (Kroll et al., 1996) and King et al (King et al., 1993; King et al., 1996), Østergaard et al 
(Østergaard, et al., 1999) introduced methodology to assess intravoxel flow heterogeneity by 
DSC MRI. The model is based on a major feeding artery in series with 20 small parallel 
vessels of equal length (Østergaard, et al., 1999). The distribution of transit times is included 
by setting appropriate flows and weights to the parallel vascular paths (King, et al., 1996; 
Østergaard, et al., 1999). Consequently, the flow heterogeneity is described by a probability 
density function assigning a probability, w(f), to a given relative flow, f, i.e. flow relative to 
the mean flow in the vascular path (Østergaard, et al., 1999). The distribution of transit times 
is extracted directly from the tissue impulse response, as Eq. [5] leads to 
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dRth −=)( .    [9] 
 
The distribution of transit times is thus given by the slope of the residue function (or the 
impulse response function) and is associated with the distribution of relative flow rates by the 
central volume theorem (Stewart, 1894)  
 
  
t
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and by requiring 
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With the assumption of all the vascular paths having equal volume, the distribution of flow 
rates follows from Eqs [10] and [11]: 
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with the normalization condition 
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4.5 Dynamic susceptibility contrast magnetic resonance imaging in describing tissue 
microcirculation 
4.5.1 Cerebral blood volume 
At the advent of DSC MRI, CBV was the parameter of interest (Rosen et al., 1989) being 
applied to cerebral neoplasms (Aronen et al., 1992b; Aronen et al., 1994; Aronen et al., 2000). 
It describes tissue perfusion from the point of view of capillary density and is fairly 
straightforward to determine. Assuming, the whole amount of contrast agent passes through 
the region of interest during the time of measurement and each molecule is observed only 
once, the measured concentration time curve is an indication of the amount of contrast agent 
particles that have passed through the region. By calculating the area under the concentration 
time curve, or rather integrating the concentration time curve with respect to time, the whole 
amount of contrast agent that has passed through the region can be determined. This measure 
is an indication of the capability of the region to pass contrast agent, and thus also blood, 
through it. In other words, it is a measure of capillary density or microvascular blood volume. 
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The limits for the integration of the concentration time curve can be selected in several ways 
and should be optimized with respect to postprocessing time, computing requirements and 
depending on whether relative or absolute values are required (Paper III). In general, for 
tracer kinetic principles to hold only the area under the tissue first pass should be calculated 
excluding second and further pass effects. 
CBV is determined as (Stewart, 1894; Meier and Zierler, 1954; Zierler, 1962; 
Zierler, 1965) 
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where κ is a scale factor accounting for the density of brain tissue and the differences in 
hematocrit and proportionality constant between capillaries and large vessels (Rempp et al., 
1994). Commonly, κ is set to 1 (Axel, 1980). As the transit of the contrast agent through the 
body is often rapid compared to cerebral vascular transit times, first and subsequent transits 
often overlap, complicating first pass area determination (Sorensen and Reimer, 2000).  
 
4.5.2 Cerebral blood flow 
Tissue perfusion is often identified with CBF. The determination of CBF is not 
straightforward, but requires knowledge of the arterial input function (AIF), which is 
inherently difficult to determine with DSC MRI. In 1996, Østergaard et al (Østergaard, et al., 
1996b; Østergaard, et al., 1996c) showed that CBF could be estimated without the need for 
knowledge about absolute arterial concentration levels. The methodology builds on the 
premise that only the shape of the AIF is required and knowledge of the absolute 
concentration levels and the underlying vascular structure can be neglected. The studies of 
Østergaard et al (Østergaard, et al., 1996b; Østergaard, et al., 1996c) showed, that CBF and 
the tissue impulse response can be determined simultaneously and fairly independently from 
the underlying vascular structure by nonparametric deconvolution of a tissue concentration 
time curve with a non-invasively determined AIF. Although this methodology as such does 
not enable the determination of the absolute CBF values it has been shown to yield gray 
matter to white matter CBF ratios in excellent agreement with PET studies (Østergaard, et al., 
1996b; Østergaard, et al., 1996c).  
 
4.5.3 Contrast agent mean transit time 
The time that it takes from blood to move from artery side to venous side, i.e. the time blood 
spends in the capillary bed, is characterized by the MTT of the contrast agent. Due to the 
inherent differences of MRI and nuclear medicine imaging techniques, the methodology for 
determining MTT as the normalized first moment of the contrast agent efflux curve can not be 
utilized with DSC MRI (Weisskoff et al., 1993). However, utilizing the methodology to 
determine CBF (Østergaard, et al., 1996b; Østergaard, et al., 1996c), MTT can be determined 
by the central volume theorem as the ratio CBV:CBF (Stewart, 1894).  
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4.5.4 Intravoxel flow distribution and oxygen metabolism 
In normal human cerebral capillaries, CBF is markedly heterogeneous (Gaehtgens, 1991; 
Kuschinsky and Paulson, 1992; Hudetz et al., 1994). This heterogeneity of CBF is believed to 
be linked to tissue oxygen metabolism regulation mechanism (Kuschinsky and Paulson, 1992; 
Gjedde et al., 1999). In states of altered cerebral hemodynamics, such as functional activation 
or lowered perfusion pressure due to a pathology, the flow velocities show a more 
homogeneous distribution (Hudetz, et al., 1996; Vogel and Kuschinsky, 1996), which is 
believed to improve oxygen delivery (Kuschinsky and Paulson, 1992; Østergaard, et al., 2000) 
thus providing a regulatory mechanism for the tissue to adapt to an altered hemodynamical 
situation. This heterogeneity of cerebral blood flow, FH, has been shown to be assessable by 
DSC MRI (Østergaard, et al., 1999). The method is based on observing the distribution of 
transit times by DSC MRI and converting that to distribution of flow values (Østergaard, et 
al., 1999)  utilizing tools originally developed for describing major vessel transport and 
microvascular tracer retention (King, et al., 1993; King, et al., 1996). The FH determined by 
DSC MRI has been shown to confirm the heterogeneous flow distribution in normal 
cerebrovascular circulation (Østergaard, et al., 1999) and homogenization of the flow 
distribution in the setting of compromised circulation in acute stroke (Østergaard, et al., 2000). 
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5 AIMS OF THE STUDY 
The study aimed to investigate the use of DWI and DSC MRI in describing human ischemic 
stroke. The specific aims were: 
 
1. to determine the apparent diffusion coefficient (ADC) for normal brain structures in healthy 
volunteers using spin echo echo planar MRI and to determine whether the ADC varies with 
age, gender, or between brain hemispheres. (Paper I) 
 
2. to determine, whether CBV, CBF, and MTT obtained using spin echo echo planar DSC 
MRI for normal brain structures in healthy volunteers vary with age, gender, or between brain 
hemispheres. (Paper II) 
 
3. to test the robustness and specificity of four commonly used post processing methods to 
determine CBV and MTT by Monte Carlo simulations, with special emphasis on the 
discrimination between normal and hypoperfused tissue and by clinical DSC MRI studies of 
patients with acute ischemic stroke. (Paper III) 
 
4. to determine whether a substantial mismatch (>50%) between reduced cerebral blood flow 
and DWI-based ischemic lesion, within 24 hours of the onset of symptoms predicts a 
substantial (>50%) growth of the infarct during the first week. (Paper IV) 
 
5. to investigate the course of abnormal cerebral blood flow heterogeneity and compare it 
with the corresponding courses of CBV, CBF, and MTT during the first week on an ischemic 
stroke, and to investigate the ability of the perfusion indices to predict clinical scale. (Paper 
V) 
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6 MATERIALS AND METHODS 
6.1 Patient and volunteer material 
The patient and volunteer material utilized in the Papers are described briefly in Table 1. The 
study protocol was approved by the ethical committee of the Departments of Neurology and 
Radiology at Helsinki University Central Hospital, or the Department of Clinical Radiology at 
Kuopio University Hospital. The study was carried out according to the Declaration of 
Helsinki and the institutional guidelines. In all cases, an informed consent was obtained from 
the volunteer, the patient or the patient’s relative prior to the study. None of the patients was 
treated with thrombolytic therapy nor did any of the patients receive experimental 
neuroprotective agents. 
 
Table 1. Overview of patient and volunteer material. 
Paper N Description 
I 80  Volunteers, age range 22-85 
II 80  Volunteers, age range 22-85 
III 13  Acute stroke patients, less than 24 hours from the onset of symptoms 
IV 57  Acute stroke patients, less than 24 hours from the onset of symptoms 
V 10 Hypercute stroke patients, less than 6 hours from the onset of symptoms 
 
6.2 Imaging hardware and sequences 
DWI and DSC MRI were performed with clinical 1.5T MR scanners (Magnetom Vision, 
Siemens Medical Systems, Erlangen, Germany) at Helsinki University Central Hospital 
(Papers I, II, V) and at Kuopio University Hospital (Papers III and IV). DSC MRI was 
performed with a spin echo EPI sequence (TR 1500ms, TE 78ms, FOV 260mm, matrix 
116×256). Seven slices were imaged repeatedly 40 times at 1.5 second intervals. Before the 
injection of contrast agent, four (Kuopio material) or seven (Helsinki material) sets of 
baseline images were collected. Gadopentetate dimeglumine (Magnevist, Schering AG, 
Berlin, Germany; 0.2 mmol/kg of body weight) was injected during the dynamic imaging into 
an antecubital vein at a constant speed of 5 ml/s using an MR compatible power injector 
(Spectris, Medrad, Pittsburgh, PA). After the injection of the contrast agent, i.v. lines were 
immediately flushed with a bolus of saline at the same injection rate. DWI was performed to 
locate the ischemic core by a spin echo EPI sequence (TR 4000ms, TE 103ms, FOV 260mm, 
matrix 96×128 interpolated to 256×256) obtaining 19 slices, each with a reference T2-
weighted image (b value, 0s/mm2) and three diffusion weighted images with orthogonally 
applied diffusion gradients (b value, 1000s/mm2).  
 
6.3 Simulation studies 
In order to assess the accuracy and precision of the four integration methods in Paper III, a 
series of Monte Carlo simulations was performed, using realistic synthetic signal time curves 
with known values for CBV, MTT, CBF, residue characteristics and covering a range of 
SNRs typical of clinical DSC MRI patient studies.  
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 6.4 Determination of apparent diffusion coefficient 
The diffusion weighted images obtained in the three orthogonal directions were coregistered 
and the natural logarithms of the images were averaged to form a rotationally invariant 
resultant image. Linear least-squares regression was used to determine the line connecting the 
resultant image and the natural logarithm of the reference T2-weighted image (b=0) on a 
pixel-by-pixel basis. The slope of the line was identified with ADC. The calculations were 
performed with a commercially available software program (MatLab, Mathsoft, Natick, MA).  
 
6.5 Determination of perfusion parameters 
CBV was determined by integrating the first pass of tissue concentration time curve within 
each voxel with respect to time. The first pass was set to begin and end at the same time for 
all the pixels, i.e. the lower and upper limits of the integration of the tissue concentration time 
curve were set based on inspection of the whole brain concentration time curve. The lower 
limit was set as the point, which visually determined was the last point before the first pass of 
the bolus, and the upper limit as the point where concentration visually determined had the 
lowest value after the first pass of the bolus, but before the appearance of recirculation. In 
Paper III, three additional methods to determine CBV were investigated. First, the upper 
integration limit was extended over the whole dynamic perfusion time series. Second, a 
gamma-variate function (Thompson Jr and Starmer, 1964; Gobbel and Fike, 1994; Boxerman 
et al., 1997)  
 
βα /)(
0
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where t0 corresponds to the tracer arrival delay, K is a constant scale factor, and α and β are 
arbitrary parameters describing the shape of the distribution, was fitted to the concentration 
time curve on a pixel-by-pixel basis and the CBV was determined as area under the fitted 
function (Boxerman, et al., 1997) 
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where Γ(x) denotes the gamma function. Third, CBV was determined as the area under the 
tissue impulse response function (Vonken et al., 1999).  
CBF was determined as the maximum value of the deconvolved tissue impulse 
response (Østergaard, et al., 1996c). 
MTT was determined through the central volume theorem (Stewart, 1894; Meier 
and Zierler, 1954) utilizing knowledge of CBV and CBF 
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CBVMTT =
.    [17] 
FH was determined from the slope of the residue function as described in 
section 4.4. The FH in each voxel was then compared, with Kolmogorov-Smirnov test, to a 
reference FH describing normal flow distribution (Østergaard, et al., 1999). The FH was 
judged abnormal in two distinct ways; if it deviated from the normal FH statistically 
significantly (P<0.05), denoted FH(05), and if it deviated from the normal FH statistically 
very significantly (P<0.01), denoted FH(01). 
 
6.6 Region of interest analyses 
In the analysis the diffusion images of the volunteer material (Paper I), 18 distinct 
neuroanatomic structures were selected for the analysis in each hemisphere. These structures 
were the frontal, parietal, temporal, occipital, and cerebellar gray matter and white matter, the 
caudate nucleus, the putamen, the thalamus, the internal capsule, the pons, and the CSF in the 
lateral ventricles (frontal horn, middle part, posterior horn). The regions of interest (ROIs) 
were manually drawn on the T2-weighted (b=0) images on which the structures could easily 
be identified. The ROIs were subsequently transferred to the corresponding ADC maps.  
In the analysis of the perfusion images of the volunteer material (Paper II), 10 
distinct neuroanatomic structures were selected for analysis in each hemisphere. These 
structures were frontal, parietal, temporal, and occipital gray and white matter, caudate 
nucleus and thalamus. First, T2-weighted images were used to identify the anatomic the 
equivalent CBV and MTT maps. Special care was taken to avoid the contamination of the 
white matter ROIs with the regions of leukoaraiosis. For each ROI, the surface area and the 
mean, SD, and range of the given values were obtained.  
In the analysis of patient data (Papers III, IV, and V), the infarcted tissue was 
determined as the region of visually judged decreased diffusion in the average diffusion 
image and, to eliminate the effect of T2-shine-through, by reviewing the area in the ADC 
image. The hypoperfused tissue was determined in CBV, CBF, MTT, and FH maps as the 
region that appeared visually abnormal compared with the corresponding contralateral region. 
The size of the ischemic lesion and the perfusion abnormality were determined by multiplying 
the corresponding area by the slice thickness and assuming the interslice gap to contain a 
lesion or an abnormality of the same surface area as the slice above it. All the ROIs were 
manually drawn and the analysis was performed with commercially available image analysis 
software (Alice, Perceptive Systems, Inc., Boulder, CO). 
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7 RESULTS 
7.1 Volunteer material 
The mean ADC values for the main brain structures are presented in Table 2. With the 
exception of the lateral ventricles, the ADC values were not affected by aging. The left and 
right hemispheres had similar ADC values, and no sex difference was found. In normal brain, 
the ADC values in both gray and white matter were within a relatively narrow range. (Paper I) 
No difference between the hemispheres was found, whereas significant 
differences between the cerebral lobes were identified in CBV, CBF, and MTT. With the 
exception of frontal and parietal cortical gray matter MTT, the perfusion parameters were not 
affected by age. Males had higher MTT and CBV than females. (Paper II) 
 
Table 2. ADC-values for the main brain structures from 80 volunteers (Paper I). The mean ± SD are presented 
with the range of values. 
  
Cortical GM 
 
WM 
 
Basal ganglia 
 
Thalamus 
 
ADC (x10-3 mm2/s) 
 
0.89 ± 0.04 
(0.78–1.09) 
 
0.70 ±  0.03 
(0.62–0.79) 
 
0.75 ±  0.03 
(0.64–0.83) 
 
0.73 ±  0.03 
(0.67–0.82) 
 
7.2 Ischemic stroke patients  
Clear differences in precision and accuracy between four different methods for determination 
of relative as well as absolute CBV and MTT values were found. The method of determining 
CBV (and MTT) did not affect the visual interpretations of tissue at risk. For relative CBV 
and MTT measurements, typical for clinical assessment of focal pathologies, numerical 
integration over the whole image range was found to be optimal in terms of computational 
efficacy, SNR, and accuracy of relative values. However, for absolute CBV and MTT 
measurements, the CBV and MTT obtained as the area under the deconvolved tissue curve by 
SVD was found to provide the most accurate estimates. (Paper III) 
In Papers IV and V, the cerebral infarct was shown to have a potential to enlarge 
after the first day. The size of initial CBF-DWI mismatch (within 24 hours of symptom onset) 
was found to roughly predict infarct growth during the first week after stroke. (Paper IV) 
The sizes of the initial perfusion abnormalities (within 6 hours of symptom 
onset) were found to decrease in size during the first week. In the hyperacute phase and at 
24hrs, the FH abnormality was shown to be larger than CBV and CBF abnormalities whereas 
no difference was observed at one week. In all three imaging sessions MTT was the largest 
perfusion abnormality. FH was shown to outperform CBV, CBF, and MTT in predicting 
clinical condition. In accordance with previous studies, the sizes of hyperacute FH, CBV, 
CBF, and MTT abnormalities were found to correlate with ischemic lesion size at 24hrs and 
at one week. (Paper V) 
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8 DISCUSSION  
8.1 Diffusion weighted imaging in acute stroke 
DWI is highly sensitive and specific to detect acute cerebral ischemia (Warach et al., 1995; 
Gonzalez et al., 1999) being more sensitive than computed tomography (Barber et al., 1999; 
Gonzalez, et al., 1999) and T2-weighted MRI (Lutsep et al., 1997; Gonzalez, et al., 1999). The 
ADC decreases rapidly in acute ischemia (Warach, et al., 1992; Weber et al., 2000; Ahlhelm 
et al., 2002) followed by a reversal in ADC in 5 to 10 days, first returning to healthy level 
(Warach, et al., 1995; Schwamm et al., 1998; Ahlhelm, et al., 2002) and subsequently rising 
above normal in chronic phase (Warach, et al., 1992; Weber, et al., 2000; Ahlhelm, et al., 
2002) due to cavitation and replacement of brain tissue with water in necrotic tissue. Due to 
the temporal evolution of the ADC values from the initially reduced values to 
pseudonormalization and further elevation above normal levels, DWI is especially useful in 
estimating the lesion age and in differentiating acute ischemic lesions from chronic ones 
(Marks et al., 1996; Singer et al., 1998; Oliveira-Filho et al., 2000). Typically, an untreated 
ischemic infarct increases in size during the first week after the insult (Sorensen et al., 1996; 
Baird et al., 1997; Barber et al., 1998; Karonen et al., 1999). Further, the increase in the 
volume of the lesion is more pronounced between the first two days of the developing infarct 
than between the second day and a week (Karonen, et al., 1999; Karonen et al., 2000a). DWI 
is already a part of clinical stroke imaging in many centers (Mullins et al., 2002). 
Whereas the lesion visible on the acute DWI generally predicts the irreversibly 
damaged ischemic core, this is not always the case; reversal of the DWI lesion back to normal 
without any intervention has been reported (Grant et al., 2001; Fiehler et al., 2002a; Fiehler et 
al., 2002b). Based on animal studies, this does not mean that the ischemic tissue would have 
fully recovered (Li et al., 1999). The results of previous studies therefore indicate that tissue 
with elevated signal intensity on DWI is not necessarily infarcted, and early normalization of 
high signal intensity lesions does not mean that the tissue will eventually survive. 
The determination of ADC requires determining at least two different diffusion 
weighted images with differing b-values. As there is no significant difference in the ADC 
estimates between using two or several b-values (Burdette et al., 1998) and as in clinical 
imaging, the imaging time is seeked to be minimized, only two different b-values are 
commonly used with the other being zero to minimize the need for sampling different 
diffusion orientations. Utilizing EPI in DWI results in an intrinsic sensitivity to magnetic field 
inhomogeneities in the form of susceptibility artefact. Although, the higher field strength 
provides higher SNR, the rise in susceptibility artefact counteracts the benefits. However, 
parallel acquisition techniques, such as sensitivity encoding (Pruessmann et al., 1999), reduce 
the sensitivity to susceptibility effects by shortening the EPI readout train and will become 
more important in higher field strengths.  
DWI captures only an isotropic approximation of the diffusion in a voxel. 
Albeit, diffusion weighted images are collected in the three orthogonal main gradient 
directions enabling the determination of the diagonal elements and the trace of the tensor, 
DWI is unable to assess true diffusion anisotropy. However, water diffusion in human tissue 
is anisotropic and a diffusion tensor is required to describe the direction-dependency of the 
diffusion (Basser et al., 1994). Building on the concept of DWI, diffusion tensor imaging 
(DTI) is a technique to map the whole diffusion tensor, including the off-diagonal elements, 
and thus determining the rotationally invariant description of the diffusion in a voxel. DTI is 
effectively able to pinpoint the directions of the highest and lowest diffusion in a voxel and 
can be used to map tissue structures with highly aligned microstructure such as white matter 
fiber tracts (Conturo et al., 1999). For a more detailed investigation of tissue microstructure, 
e.g. fiber crossing, more advanced data collection and analysis techniques are required. Some 
23 
that have been suggested include multitensor imaging (Tuch et al., 2002) and diffusion 
spectrum imaging and q-ball imaging (Tuch et al., 2003), both of which are based on q-space 
methodology (Callaghan, 1993). However, the drawback of these more advanced methods is 
the significantly longer imaging time required to sample the data and relatively demanding 
analysis methodology, which have delayed the incorporation of these techniques into clinical 
stroke imaging. 
 
8.2 Limitations of dynamic susceptibility contrast magnetic resonance imaging 
8.2.1 Utilization of the susceptibility effect 
Compartmentalization. In normal brain, the BBB keeps the contrast agent compartmentalized 
in the intravascular space. Especially neoplastic growth and in rare occasions also 
cerebrovascular disease, may affect the permeability of BBB and consequently blood and the 
contrast agent are able to leak into the tissue. This leakage prevents the utilization of 
susceptibility contrast as it is masked by the T1-effects arising from extravascular contrast 
agent concentration. As the blood volume in a voxel is typically very small (around 2-4%) 
(Fisel, et al., 1991), even a small amount of leaked contrast agent is enough to effectively 
cancel the susceptibility effect. In practice, the leakage results in a severe miscalculation of 
CBV, as the signal in the tissue concentration time curve rises well above baseline and 
subsequently reduces the temporal integral over the curve. There are several methods to 
account for the increased T1 enhancement. One such method is to use a contrast agent that 
produces minimal T1 enhancement such as dysprosium. However, in clinical use this is an 
undesirable property as post-contrast T1-weighted images are routinely required. Another 
method to account for the T1 enhancement is to apply a predose of contrast agent saturating 
the interstitial space before the execution of DSC imaging. The most novel method is to 
simultaneously model both T1 and T2 enhancements and thus acquire the maximum amount 
of information from the first pass passage of the contrast agent (Weisskoff et al., 1994a; 
Østergaard et al., 1996a). The methodology is based on dividing the observed concentration 
into intra- and extravascular components. The intravascular component is assumed to be 
proportional to the vascular signal in a nonleaky reference region, which is considered as an 
input function for the extravascular component. This method allows the determination of the 
leakage-corrected CBV and additionally the permeability of vascular endothelium. 
Concentration of the contrast agent.  As the contrast agent concentration and T2 
relaxation rate are approximately linearly dependent (Villringer, et al., 1988; Rosen, et al., 
1990; Fisel, et al., 1991; Kennan, et al., 1994; Weisskoff, et al., 1994b; Boxerman, et al., 
1995; Lev, et al., 1997), the higher the contrast agent concentration the higher the signal drop 
during the first pass of the agent and consequently the better quality of the post processed 
perfusion maps (Boxerman et al., 1992). The quality can be enhanced by increasing injection 
speed tightening the contrast agent bolus or by using a contrast agent with higher 
susceptibility effect, e.g. dysprosium, reducing the amount of required contrast agent 
(Sorensen and Reimer, 2000). It has been demonstrated that perfusion maps (CBV) produced 
by higher doses of contrast have better SNRs and are able to depict more detailed anatomical 
and pathological structures than the lower dose maps (Aronen et al., 1992a; Aronen et al., 
1992c). The utility of CBV maps depends strongly on the on the SNR of the maps (Boxerman, 
et al., 1997) indicating that the perfusion raw data should be collected with as high an SNR as 
possible. The injected dose as such does not affect gray:white CBV ratios (Lev, et al., 1997). 
Most of the clinical studies have been performed using 0.5 molar gadolinium chelates 
(gadopentetate dimeglumine, gadodiamide, gadoteridol, gadolinium-DO3A, gadobenate 
dimeglumine, gadoversetamide) with doses of 0.1-0.2 mmol/kg body weight (Sorensen and 
Reimer, 2000). A 1.0 molar gadolinium chelate (gadobutrol) has been evaluated for cerebral 
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perfusion in a multicenter study reporting the dose 0.3 mmol/kg being optimal with gradient 
echo sequences at 1.0 Tesla field strength (Benner et al., 2000).  
Injection speed. Although, the indicator dilution theory is valid for both 
instantaneous and continuous injections, to obtain the concentration levels necessary for the 
susceptibility contrast in DSC MRI, the injection of the contrast agent has to be concise. If the 
injection of the tracer is slow (infusion) the T1-effects of the tracer dominate over the 
susceptibility effects (Villringer, et al., 1988). Consequently, in DSC imaging the tracer has to 
be injected as a bolus. Ideally, the bolus would be infinitely short allowing the straightforward 
utilization of the tracer kinetic principles. However, practical constraints limit the injection 
speed distributing the contrast agent to a finite bolus. In practice, an automated power 
injection is required to maintain constant injection speed and to produce constant bolus shape 
(Sorensen and Reimer, 2000). The injection of a saline bolus right after the contrast agent 
bolus helps the passage of the contrast agent bolus to the heart and reduces the dispersion, 
which the bolus experiences on its passage through the vasculature. The injection rate into a 
peripheral vein is typically 5ml/second. The contrast-to-noise ratio of CBV maps is dependent 
on the contrast agent dose but not on the injection rate (Lev, et al., 1997). However, when 
extracting information about CBF, MTT, and the characteristics of the residue function, 
where the identification of the arterial input function is needed, the faster injection rate may 
be beneficial. 
Field strength. The sensitivity to susceptibility effect increases with the field 
strength (Villringer, et al., 1988). This has direct consequences for the quality of perfusion 
images. First, it enables increasing the temporal sampling frequency in higher field strength 
by maintaining contrast agent dose. Alternatively, the contrast agent dose can be reduced to 
maintain the level of perfusion image quality of lower field strength. Maintaining both 
temporal sampling frequency and contrast agent dose, the higher field allows to decrease the 
noise content in the tissue concentration time curve and thus improve the accuracy of the 
perfusion parameter estimates.  
Deconvolution technique. As DSC MRI data is inherently noisy, the method of 
performing the deconvolution is crucial for obtaining reliable and repeatable results. There are 
broadly two kinds of methods available; those that assume a function for the tissue tracer 
retention, the model-dependent methods, and those that do not, the model-independent 
methods. Østergaard et al. (Østergaard, et al., 1996b; Østergaard, et al., 1996c) showed that 
model-independent techniques yield better estimates of the underlying CBF values 
independent of the vascular structure with the optimal method being SVD. However, SVD 
has the tendency of underestimating CBF in the case of delayed tissue tracer input compared 
to the arterial input function as it cannot distinguish between delayed input and increased 
transit time (Calamante et al., 2000). Even though a straight delay of tracer arrival can, in 
theory, be accounted for, modelless approaches cannot distinguish tracer dispersion in feeding 
vessels from tracer retention in capillary bed: large vessel dispersion will be interpreted as a 
low flow (Østergaard, et al., 1996b; Østergaard, et al., 1996c; Calamante, et al., 2000). The 
use of model-independent techniques to assess tissue tracer retention eliminate the 
requirement of models describing vascular structure and function. Whereas the use of these 
kind of models allows distinguishing major vessel dispersion and microvascular retention as 
well as the identification of tracer arrival delays, they have to be used very carefully not to 
lose generality and thereby bias the determined indicators of tissue perfusion.  
 
8.2.2 Signal acquisition  
As both T2 and T2* are sensitive to susceptibility contrast, both spin and gradient echo –
based pulse sequences can be used to detect it. Gradient echo sequences do not employ full 
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refocusing of the magnetic field inhomogeneities, and the signal loss subsequently arises 
directly from the microscopic susceptibility gradients that cause local changes in the 
resonance frequency of water protons. Spin echo sequences, however, do employ full 
refocusing of the magnetic field inhomogeneites, which accounts for these changes and hence 
appreciable signal loss is not registered but instead the signal loss in spin echo sequences is 
caused by the diffusion of water into areas of different local magnetic fields and is observed 
with long echo times. It has been demonstrated by theoretical modeling and by Monte Carlo 
simulations that spin echo measurements are mainly sensitive to vessels of a size similar to 
the water diffusion length (<20µm), whereas gradient echo measurements are less dependent 
on the vessel size (Fisel, et al., 1991; Weisskoff, et al., 1994b; Boxerman, et al., 1995). Similar 
results have been found in human brain (Speck et al., 2000). In other words, spin echo 
sequences are more sensitive to microvasculature than gradient echo sequences and thus 
provide information more closely linked with the properties of capillaries than gradient echo 
sequences. The drawback in spin echo sequences is their lower SNR compared with gradient 
echo sequences: gradient echo sequences with a dose of 0.1 mmol/kg of gadolinium-DTPA 
contrast agent produce a susceptibility effect (signal loss in the brain) of a magnitude 
approximately similar to spin echo sequences with with a dose of 0.2 mmol/kg (Aronen, et al., 
1992a). The inherent difference between spin and gradient echo techniques enables the 
determination of an index describing the difference of the two techniques. The index can be 
determined by a hybrid pulse sequence including alternating gradient and spin echo –based 
data collection during the same first pass circulation through human brain and expressed in 
the form of the ratio ∆R2*/∆R2, which serves as an indicator of vessel size (Dennie et al., 
1998; Donahue et al., 2000). 
 
8.2.3 Determination of the arterial input function 
The AIF is a prerequisite to utilize the indicator dilution theory for determining CBF and 
subsequently MTT and FH. Due to inter alia the fact that microvascular and major vessel 
hematocrit differ in the brain due to rheologic effects (Lammertsma et al., 1984), the 
proportionality constant relating signal and concentration is not equal for tissue and major 
vessels. The conversion of signal into concentration by Eq. [3] does therefore not apply for 
the AIF as it does for the brain parenchyma. Subsequently, the area under the curve for AIF 
and tissue concentration time curve cannot be directly compared. Whereas the shape of the 
AIF can be determined with rather good accuracy (Porkka et al., 1991), the height of the 
function remains arbitrary and thus the size of the AIF has to be normalized to the injected 
dose to produce quantitative results (Axel, 1980; Rosen, et al., 1990). Further, sensitivity to 
signal change is a function of vessel size so that the amount of signal change is not the same 
in large and small vessels for a given amount of gadolinium. The methodology is thus highly 
sensitive to the individual details of microvascular architecture (Kiselev, 2001).  
The signal loss in the vicinity of a major artery arises due to dephasing of spins 
near a single vessel. The field gradients due to the artery, which cause spin dephasing, depend 
on the orientation of the vessel relative to the magnetic field and the size of the vessel, which 
are very difficult to measure from DSC images. The signal loss in the tissue, however, is due 
to dephasing of spins in field gradients produced by an essentially random distribution of 
blood vessels with random sizes and orientations (Boxerman, et al., 1995). Consequently, in 
tissue voxel the orientation of a single capillary does not bias the signal from the whole voxel 
and a reasonable approximation for the quantitative relationship between the tissue signal and 
contrast agent concentration is conceivable. However, it is not possible to measure absolute 
concentrations of contrast agent within an artery. The long echo times optimized for tissue 
signal loss may cause complete signal loss at major vessels (Ellinger et al., 2000). For this 
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reason, smaller arterial branches with partial volume effects with surrounding tissue are used 
to determine the shape of the arterial input function (Østergaard, et al., 1996b; Østergaard, et 
al., 1996c). 
 Ideally, AIF should be unique for each imaging voxel, but that is in practice not 
plausible. Commonly, a single AIF is selected for the whole brain (Østergaard, et al., 1996b) 
or brain hemisphere (Thijis et al., 2004). Typically, the AIF is estimated from a branch of the 
middle cerebral artery with the assumption, that the AIF for each individual voxel has the 
same characteristics and that the contrast agent reaches all parts of the brain at the same time 
and without significant dispersion during its passage from the major artery to the brain 
parenchyma. However, even in normal brain there is delay and dispersion, which in patients 
with cerebrovascular disease is pronounced, introducing inaccuracy in the perfusion estimates 
(Calamante, et al., 2000). The occluded vessels themselves can contribute to a delay in the 
arrival time of the contrast agent and dispersion of the shape of the bolus at the imaging 
voxel. The CBF estimates are therefore be dependent on the site of AIF measurement (Wu et 
al., 2003b; Thijis, et al., 2004). It has been shown that when the AIF leads the tissue, CBF is 
underestimated independent of extent of delay, but dependent on MTT (Wu et al., 2003a). 
Further, when the AIF lags the tissue, flow may be over- or underestimated depending on 
MTT and extent of timing differences (Wu, et al., 2003a). There are a number of methods 
being developed to overcome these obstacles. A method to obtain arrival timing-insensitive 
flow estimates and hence a more specific indicator of ischemic injury have been introduced 
(Wu, et al., 2003b). One possible solution to more accurately estimate the AIF is determining 
AIF locally for a group of voxels (Alsop et al., 2002), in seeking to approximate the true input 
to a voxel. 
 
8.2.4 Quantification issues 
Due to problems described above, quantification of perfusion indices is not straightforward. 
The problems have been circumvented by assuming uniform values for hematocrite in the 
capillaries and large vessels (Hartery / Hcapillaries = 0.45/0.25), and assuming the same 
proportionality constant for both tissue and the arteries (Rempp, et al., 1994). However, tissue 
hematocrite is in fact a complex function of, e.g. vessel size and physiological conditions and 
thus likely to be subject dependent. Alternatively, absolute values can be estimated by cross-
calibration with another technique (Østergaard et al., 1998a; Østergaard et al., 1998b). This 
methodology utilizes the same technique for determining relative CBF as described above 
regarding only information of the shape of the AIF and neglecting the estimate for absolute 
arterial concentration. The area of the AIF is assumed to be proportional to the injected 
contrast dose and an estimate for the ‘true’ CBF is subsequently obtained from the measured 
CBF with a conversion factor. The conversion factor has been determined by comparing a 
sample set of DSC MRI flow values with those obtained by positron emission tomography 
(Østergaard, et al., 1998a; Østergaard, et al., 1998b). However, cross-calibration has been 
investigated only within young healthy subjects and the assumption that the same fraction of 
cardiac output reaches the brain may not hold true with aging or in pathological 
microcirculation. In pathophysiological condition, a correction factor based on the area of the 
venous output function, measured from the superior sagittal sinus has been demonstrated to 
provide enhanced the accuracy of the CBF estimates (Lin et al., 2001). Cross-calibration thus 
suggests to be one of the most promising methods to quantify perfusion values by DSC MRI. 
Whereas the actual predictive value of DWI and DSC MRI of stroke evolution remains at the 
group level, these techniques already are a vital part of clinical decision making and are 
actively being developed to allow forming risk profiles on an individual basis. 
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8.3 Imaging stroke with diffusion and dynamic susceptibility contrast perfusion 
weighted imaging 
Typically in acute stroke, a perfusion abnormality in the DSC–based images exceeds the 
DWI–based ischemic lesion (Sorensen, et al., 1996; Barber, et al., 1998; Rordorf et al., 1998; 
Karonen, et al., 1999; Sorensen et al., 1999; Parsons et al., 2001). The difference in size 
between the perfusion abnormality and the DWI –based lesion is referred to as diffusion-
perfusion mismatch and is considered to be an estimate of the ischemic penumbra, tissue 
where the neurons are functionally silent but structurally intact and thereby potentially 
salvageable with recanalization (Sorensen, et al., 1996; Karonen, et al., 1999; Schlaug et al., 
1999; Karonen et al., 2000b) 
Combined diffusion– and perfusion–weighted imaging has been shown to be 
able to detect hemodynamically different subregions inside the initial perfusion abnormality 
(Liu et al., 2000). Further it has been shown, that tissue survival may be different in these 
subregions and may be predicted (Liu, et al., 2000). Also the detection of T1 contrast 
enhancement has been shown to assist in determining the age of infarct (Karonen et al., 2001). 
Liu et al. have found genetic bias in the eplison 4 carriers to show enhanced infarct growth 
during the first week supporting the increased general vulnerability of the brain in the epsilon 
4 carriers (Liu et al., 2002). 
Recently, the use of DSC imaging has been extended to address oxygen delivery 
to tissue. The methodology is based on oxygen delivery being limited by the capillary surface 
area and the affinity of oxygen to hemoglobin even for modest CBF values (Gjedde, et al., 
1999). By measuring the capillary surface area, which is determined indirectly from 
microvascular blood volumes, flow, and the intravoxel flow distribution, the net flow of 
oxygen into tissue can be predicted and estimates for oxygen extraction fraction (OEF) and 
cerebral metabolic rate of oxygen (CMRO2) determined (Østergaard et al., 2001). 
Measurement of ADC combined with perfusion MRI may help distinguish 
different subregions in acutely hypoperfused brain (Liu et al., 2003). Further, it has been 
shown, that the assessment of the risk of infarction is obtained with higher specificity and 
sensitivity with algorithms that combine acute DWI and PWI than with algorithms that use 
DWI or PWI individually (Wu et al., 2001). This underlines the importance of utilizing both 
methods in the acute stroke imaging protocol. Additionally, phase-contrast MR angiography 
has been shown to provide complementary information to that with diffusion- and perfusion- 
weighted imaging in predicting the outcome of patients with acute stroke (Liu et al., 2004), it 
is important to include angiography in the imaging protocol.  
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9 CONCLUSIONS 
In the present study, the application of combined DWI and DSC MRI in normal aging and in 
ischemic stroke was evaluated. The effect of normal aging and normal brain subregional 
differences on the normal variation of ADC and perfusion indices were reported as well as the 
behavior of the sizes of DWI, CBV, CBF, MTT, and FH –based abnormalities in an untreated 
ischemic stroke during the first week. Further, by reporting the failure of traditional and the 
success of more novel methods to accurately determine CBV and MTT, the study lays ground 
for quantitative measures of DSC MRI indices. The main conclusions are: 
 
1. the ADC values, determined using spin echo EPI, for normal brain structures in healthy 
volunteers (age range 22-85 years) are unaffected by age in normal gray and white matter, 
and the ADC values are not biased according to brain hemisphere or gender. (Paper I) 
 
2. in healthy volunteers (age range 22-85 years), there is no difference between the 
hemispheres, whereas there are significant differences between the cerebral lobes in CBV, 
CBF, and MTT determined by spin echo EPI. With the exception of frontal and parietal 
cortical gray matter MTT, the perfusion parameters are not significantly dependent on 
age. Males have higher MTT and CBV than females. (Paper II) 
 
3. the method of determining CBV (and MTT) does not affect the visual interpretations of 
tissue at risk. However, a method taking into account the recirculation effects of the 
contrast agent have to be utilized for assessing perfusion on a quantitative level. (Paper 
III) 
 
4. a substantial mismatch (>50%) between initial CBF-DWI mismatch (obtained within 24 
hours of symptom onset) is associated with substantial (>50%) infarct growth during the 
first week after stroke. (Paper IV) 
 
5. the sizes of the initial perfusion abnormalities (within 6 hours of symptom onset) decrease 
in size during the first week of ischemic stroke. The mean FH abnormality is larger in size 
than the mean CBV and CBF abnormalities, but smaller than the mean MTT, in the 
hyperacute phase and at 24hrs, whereas there is no difference at one week. FH may be 
superior to CBV, CBF, and MTT in predicting clinical condition. (Paper V) 
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